Research Article

Streptococcus iniae M-Like Protein Contributes to Virulence in Fish and Is a Target for Live Attenuated Vaccine Development

  • Jeffrey B. Locke,

    Affiliations: Department of Pediatrics, University of California San Diego, La Jolla, California, United States of America, Center for Marine Biotechnology & Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, California, United States of America

  • Ramy K. Aziz,

    Affiliation: Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt

  • Mike R. Vicknair,

    Affiliation: Kent SeaTech Corporation, San Diego, California, United States of America

  • Victor Nizet,

    Affiliations: Department of Pediatrics, University of California San Diego, La Jolla, California, United States of America, Center for Marine Biotechnology & Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, California, United States of America, Skaggs School of Pharmacy & Pharmaceutical Sciences, University of California San Diego, La Jolla, California, United States of America

  • John T. Buchanan mail

    Affiliations: Department of Pediatrics, University of California San Diego, La Jolla, California, United States of America, Aqua Bounty Technologies, San Diego, California, United States of America

  • Published: July 30, 2008
  • DOI: 10.1371/journal.pone.0002824



Streptococcus iniae is a significant pathogen in finfish aquaculture, though knowledge of virulence determinants is lacking. Through pyrosequencing of the S. iniae genome we have identified two gene homologues to classical surface-anchored streptococcal virulence factors: M-like protein (simA) and C5a peptidase (scpI).

Methodology/Principal Findings

S. iniae possesses a Mga-like locus containing simA and a divergently transcribed putative mga-like regulatory gene, mgx. In contrast to the Mga locus of group A Streptococcus (GAS, S. pyogenes), scpI is located distally in the chromosome. Comparative sequence analysis of the Mgx locus revealed only one significant variant, a strain with an insertion frameshift mutation in simA and a deletion mutation in a region downstream of mgx, generating an ORF which may encode a second putative mga-like gene, mgx2. Allelic exchange mutagenesis of simA and scpI was employed to investigate the potential role of these genes in S. iniae virulence. Our hybrid striped bass (HSB) and zebrafish models of infection revealed that M-like protein contributes significantly to S. iniae pathogenesis whereas C5a peptidase-like protein does not. Further, in vitro cell-based analyses indicate that SiMA, like other M family proteins, contributes to cellular adherence and invasion and provides resistance to phagocytic killing. Attenuation in our virulence models was also observed in the S. iniae isolate possessing a natural simA mutation. Vaccination of HSB with the ΔsimA mutant provided 100% protection against subsequent challenge with a lethal dose of wild-type (WT) S. iniae after 1,400 degree days, and shows promise as a target for live attenuated vaccine development.


Analysis of M-like protein and C5a peptidase through allelic replacement revealed that M-like protein plays a significant role in S. iniae virulence, and the Mga-like locus, which may regulate expression of this gene, has an unusual arrangement. The M-like protein mutant created in this research holds promise as live-attenuated vaccine.


Streptococcus iniae is a significant finfish pathogen responsible for annual losses in aquaculture exceeding $100 million [1]. Though originally isolated from a freshwater Amazon dolphin (Inia geoffrensis) [2], and capable of causing infection in elderly or otherwise immunocompromised humans [3], S. iniae is predominantly a fish pathogen with a broad host range of fresh and saltwater species such as trout, tilapia, salmon, barramundi, yellowtail, flounder, and hybrid striped bass (HSB) [4]. Mortality resulting from S. iniae is often attributed to meningoencephalitis which manifests following systemic dissemination of bacteria through the bloodstream and major organs [4]. Currently there are no commercial vaccines approved for prevention of S. iniae infection in US aquaculture.

Our understanding of S. iniae pathogenesis is limited. To date only three S. iniae virulence factors have been characterized in the context of fish virulence: the capsular polysaccharide which contributes to phagocyte resistance [5], [6]; the cytolysin streptolysin S which contributes to host cell injury [7], [8]; and phosphoglucomutase, which is required for cell wall rigidity and resistance to cationic antimicrobial peptides [9]. In each case, the identified S. iniae virulence determinant shared homology with counterparts expressed by other major streptococcal pathogens of humans and/or animals. In an effort to identify additional genes involved in S. iniae pathogenesis, we have used pyrosequencing [10] (454 Life Sciences) of a virulent isolate to identify candidate genes sharing homology with proven virulence factors of the leading human pathogen, Streptococcus pyogenes (group A Streptococcus, GAS), a well characterized close genetic relative of S. iniae [11].

In GAS, many virulence genes are part of a pathogenicity regulon known as Mga (multiple gene regulator of group A Streptococcus) [12], [13]. Mga is a “stand-alone” global gene regulator that exerts positive transcriptional regulation on downstream genes in the proximal Mga locus, and distally in the genome through binding of the Mga protein to consensus upstream promoter regions [14], [15]. The most extensively studied component of the Mga regulon is M protein, a surface-anchored virulence factor [16], [17] that contributes to GAS cellular adherence and invasion [18], [19], resistance to phagocytic clearance [20], [21], host inflammatory activation [22], [23], and serotypic diversity [24], [25]. Other members of the GAS Mga regulon include genes for additional M-like surface proteins and the gene encoding the C5a peptidase ScpA, a bifunctional virulence factor capable of inactivating the complement derived neutrophil chemoattractant C5a [26], [27], while also contributing to GAS epithelial cell adhesion [28].

Here we identify genes simA and scpI in a virulent S. iniae isolate which share homology with genes encoding the GAS Mga-associated virulence factors M-like protein and C5a peptidase, respectively. We provide bioinformatic analyses of these two genes and the S. iniae Mga-like Mgx locus, comparing different S. iniae isolates and other streptococcal pathogens. Through targeted allelic replacement mutagenesis coupled with in vitro and in vivo models of S. iniae pathogenesis, we assess the roles of these genes as virulence determinants of this leading aquaculture pathogen, and demonstrate a key role for simA. Finally, we examine the utility of the ΔsimA mutant as a live attenuated vaccine.


SiMA and its relationship to other streptococcal M family proteins

The 1,566 bp M-like protein gene simA, from S. iniae strain K288, encodes a 521 amino acid gene product, SiM (S. iniae M-like protein), with a predicted precursor protein mass of 57.5 kDa. This M-like protein gene is identical to the recently published simA gene sequences from S. iniae strains QMA0076 and QMA0131 [29]. BLAST (tblastn) analysis groups SiMA closest to the S. uberis lactoferrin binding protein, Lbp (32% identity, 49% positive) [30] and the S. dysgalactiae subsp. dysgalactiae (GCS) M-like protein, DemA (31% identity, 51% positive) [31], though SiMA has near comparable similarity to a number of other streptococcal M family proteins (Fig. 1A). Amino acid sequence alignments between SiMA and related M family proteins, as expected, showed the highest degree of similarity in the C-terminus which includes the LPXTG Gram-positive surface anchor motif (Fig. 1B, S1) [32].


Figure 1. Bioinformatic analysis of SiMA.

(A) Phylogenetic clustering of SiMA shows greatest similarity to other streptococcal M family proteins, most closely the S. uberis lactoferrin binding protein. (B) Amino acid sequence alignments of SiMA with other streptococcal M family proteins shows highest conservation in the C-terminal region which includes the LPXTG surface anchor motif. Strain abbreviations: SIn–S. iniae, SPy–S. pyogenes, SUb–S. uberis, SEq–S. equi, and SDy–S. dysgalactiae.


sim sequences are highly conserved across a diverse panel of S. iniae isolates

The sim genes from a panel of 11 S. iniae isolates from various hosts and geographical regions in North America were analyzed for DNA sequence similarity (Table 1). Only three of these strains (29178, 95006, and 02161A) varied from the simA consensus sequence defined in the wild-type (WT) K288 strain, a finding consistent with previous observations [29]. ATCC strain 29178 (freshwater dolphin abscess isolate) possesses a silent A→G single nucleotide polymorphism (SNP) in nucleotide 741, maintaining the Gln-247 residue, and is identical to the simA allele sequence for the QMA0140 dolphin isolate [29]. Another A→G SNP was found in strain 95006 (tilapia abscess isolate) at nucleotide 1,430, changing Gln-477 to Arg-477. The most significant sim sequence variation was found in a tilapia brain isolate (02161A), which possess a 40 bp insertion duplication starting at bp 595. This insertion generates a frameshift mutation splitting the gene into two potential ORFs, likely leading to severely altered or absent function. The first ORF is predicted to encode a truncated N-terminal SiM fragment of predicted 22.7 kDa mass, but would lack the LPXTG consensus motif for sortase-mediated cell wall anchoring of Gram-positive surface proteins. The second ORF would encode a C-terminal SiM fragment of 33.7 kDa containing the LPXTG motif, but would lack the hydrophobic N-terminal leader sequence involved in protein secretion.


Table 1. Information on S. iniae strains used in sim gene sequencing.


ScpI and its relationship to other streptococcal C5a peptidase-family genes

The S. iniae scpI (Streptococcal C5a peptidase-like gene of S. iniae) gene is 3,369 bp in length and encodes a predicted 1,122 amino acid gene product with a mass of 123.3 kDa. BLAST (tblastn) analysis indicates ScpI has equal degrees of similarity (37% identity, 55% positive) to the C5a peptidases of GAS (ScpA of the Manfredo M5 strain) [33] and group B Streptococcus (S. agalactiae, GBS) (ScpB of the A909 strain) [34]. Though the proteolytic functionality of ScpI is unknown, it does contain the conserved serine protease catalytic triad of Asp-130, His-193, and Ser-512 [35]; however due to differences in overall protein size these conserved residues fall at slightly different locations in ScpI (Asp-114, His-181, Ser-501) (Fig. S2). Analysis of ScpI also indicates conservation of the C-terminal LPXTN cell surface anchor motif (Fig. S2).

S. iniae does not possess a GAS-like Mga locus

S. iniae does not possess a typical GAS-like Mga locus arrangement containing M family protein and C5a peptidase genes, where these genes in GAS are located adjacently and downstream of the mga gene transcribed in the same direction [15]. Unlike GAS, in S. iniae strain K288, the M-like protein gene (simA) is located adjacent to a divergently transcribed mga-like gene, mgx (Fig. 2A) and the C5a peptidase gene (scpI) is located elsewhere on the chromosome. The Mga-like Mgx shares almost complete amino acid similarity (98.2% identity, 98.4% positive) with the Mgx sequence reported for S. iniae strain QMA0076 [29]. The limited sequence variation is isolated to the C-terminal amino acids leading up to and including 7 additional amino acids found in the Mgx proteins of strains K288 and 9117 (a human isolate currently being sequenced by Baylor College of Medicine Human Genome Sequencing Center, BCM-HGSC) which extend beyond the 495 amino acid Mgx protein found in strains 02161A and QMA0076. S. iniae Mgx is most similar (tblastn, 39% identity, 58% positive) to the Mga-like Mgc putative regulatory protein of S. dysgalactiae subsp. equisimilis (GCS/GGS) [36].


Figure 2. Allelic exchange mutagenesis of simA and scpI.

Allelic exchange mutagenesis of simA (A) and scpI (B) was carried out by using knockout plasmids (pKOsimA and pKOscpI) containing ~1,000 bp flanking regions upstream (Up) and downstream (Down) nesting the cat gene in between. The plasmid also contains Erm resistance (ErmR) and a temperature-sensitive origin of replication (t.s. repl.). Through two independent single crossover events, the S. iniae simA and scpI genes were precisely replaced in-frame by the cat gene. (A) The simA gene is located adjacent to a putative mga-like regulatory gene, mgx. Downstream is a divergently transcribed, putative tellurite resistance protein (telX). (B) The scpI gene lies upstream from a putative sugar ABC transporter gene (satA). A putative transposase (tnpA) flanks the downstream end of scpI followed by the phosphoglucomutase gene (pgmA).


Our sequencing efforts, as well as the BCM-HGSC 9117 genome project, indicate the presence of a chromosomal region downstream from mgx which encodes two ORFs with high BLAST similarity to regions of Mgx and other Mga-like regulatory proteins, potentially representing an evolutionary distant duplication of a mga-like gene, whose function was lost through mutations over time (Fig. 3). Strain 02161A, however, through sequence variation in this region, including a 117 bp deletion, possesses a 1,326 bp ORF which may encode a second putative mga-like regulatory gene, mgx2 (Fig. 3). The 441 amino acid mgx2 gene product, Mgx2, has a predicted mass of 51.7 kDa and is most similar (tblastn) to the Mgx protein of S. iniae QMA0076 (42% identity, 58% positive) [29], the DmgB Mga-like protein of GCS strain Epi9 (32% identity, 52% positive) [31], and the Mga protein of GAS strain MGAS8232 (32% identity, 53% positive) [37].


Figure 3. Nucleotide and ORF variability in the S. iniae Mga-like Mgx region.

The S. iniae putative mga-like gene mgx and the putative tellurite resistance gene telX are highly conserved in strains K288, 9117, and 02161A. 02161A, however, has significant variation in the Mgx chromosomal region primarily due to four deletion or insertion sequences (A–D), two of which affect coding sequences. A 40 bp insertion/duplication (D) in the simA M-like protein gene splits it into two ORFs whose transcription and function is unknown. A 117 bp deletion (A) in the upstream mgx region generates a second putative mga-like gene, mgx2. In K288 and 9117 the mgx2 region is broken into two smaller ORFs. Similarity between adjacent strains is indicated as % nucleotide identity.


Almost exactly halfway between the divergently transcribed mgx and simA genes (162 bp upstream from the simA start codon ) lies a highly conserved 51 bp region, identical in isolates K288, 9117, 02161A and QMA00131 [29] (Fig. 4). This region has similarity to the established 45 bp Mga binding site for the emm6.1 gene of M6 GAS [14] and a 47 bp region upstream of the S. uberis lactoferrin binding protein gene [30] (Fig. 4). Downstream from simA is a putative tellurite resistance protein gene, telX, encoding a gene product with 99% identical amino acid composition to the TelX protein of S. iniae strain QMA0076 [29]. The chromosomal arrangement of mgx, simA, and telX was identical in S. iniae strains K288, 9117, 02161A, and QMA0076 [29]. Aside from insertion and deletion mutations in 02161A, nucleotide level analysis of the remainder of the Mgx locus reveals high conservation between strains (Fig. 3).


Figure 4. Comparison of putative Mga-like binding motifs upstream of sim genes.

The 51 bp upstream regions of S. iniae sim genes with high similarity to GAS emm gene Mga binding sites are identical in strains K288, 9117, and 02161A. A 47 bp sequence sharing similarity to Mga-like binding sites located upstream of the gene encoding the S. uberis lactoferrin binding protein (Lbp, a close phylogenetic relative of SiMA) is also included for comparison. S. iniae and S. uberis putative binding motifs are aligned with the established 45 bp Mga binding site found in M6 GAS upstream of the emm6.1 M protein gene. Abbreviations: SIn–S. iniae, SUb–S. uberis, SPy–S. pyogenes.


Unlike GAS, but similar to the chromosomal positioning in GCS and GGS [36], the S. iniae scpI gene is located outside of the Mga-like locus of the chromosome (Fig. 2B) and does not possess an upstream promoter region similar to binding motifs present in Mga-regulated GAS scpA genes [14]. ScpI is bordered downstream by a divergently transcribed putative transposase (tnpA), a 237 bp ORF encoding a 78 amino acid gene product. TnpA has highest similarity (tblastn, 66% identity, 78% positive) within an overlapping 50 amino acid region of “IS861, transposase orfB” in the GBS A909 genome [34]. A transposase is one of the insertional elements flanking the GBS scpB chromosomal region and is thought to be involved in horizontal gene transfer [38]. Immediately upstream of the transposase is the phosphoglucomutase gene (pgmA) which has been implicated in S. iniae fish virulence [9]. Upstream of scpI lies a 957 bp putative sugar ABC transporter gene (satA) with high similarity (tblastn, 90% identity, 96% positive) to the putative ABC sugar transporter SPy_1225 of GAS M1 strain SF370 [39]. The presence of scpI and tnpA in between the satA and pgmA genes in the S. iniae chromosome also supports horizontal transfer theories since the homologues of satA and pgmA in GAS are located adjacently in the genome [39].

Allelic replacement of simA and scpI conserves key S. iniae phenotypic properties

Precise in-frame allelic replacement of simA and scpI (Fig. 2A, B) generated viable mutants which retain most WT phenotypic characteristics. In particular, no differences between the ΔsimA or ΔscpI mutant and the WT K288 parent strain were observed in coccoid morphology (Fig. 5A), cell buoyancy which is correlated to encapsulation (Fig. 5B), hemolytic activity against fish red blood cells (Fig. 5C), or cell surface charge (Fig. 5E). The ΔsimA mutant did enter stationary phase at a slightly higher optical density than either the WT K288 or the ΔscpI mutant (Fig. 5D) and the ΔscpI mutant had a slightly increased frequency of multimeric cocci chains than the other two strains (Fig. 5A).


Figure 5. Basic phenotypic properties of S. iniae are highly conserved following allelic replacement of simA and scpI.

(A) Cocci chain morphology was observed under light microscopy (Crystal Violet staining viewed under an oil immersion 100× objective). (B) General buoyancy characteristics of the strains were observed in overnight cultures grown in 15 ml conical tubes. (C) Hemolytic activity was measured through the optical density of the supernatant following incubation of HSB red blood cells with bacteria. (D) Growth rate was measured optically every 45 min in 5 ml tube cultures. (E) Bacterial cell surface charge was indirectly measured through the absorbance of unbound, positively charged cytochrome c, following incubation with bacteria.


S. iniae M-like protein contributes to virulence in HSB and zebrafish infection models

Using our established S. iniae HSB infection model system [9] we analyzed the overall requirement of simA and scpI for fish virulence following intraperitoneal (IP) or intramuscular (IM) challenge. Compared to the WT K288 strain, the isogenic ΔsimA mutant was completely attenuated in the HSB IP challenge (P<0.0001) (Fig. 6A) and caused only 10% mortality in the IM challenge group (P<0.001) (Fig. 6B). An IP challenge in HSB with 1,000 times the lethal WT K288 dose (3×108 CFU) of the ΔsimA mutant was required to generate comparable mortality to WT K288 (data not shown). Similar to the K288 ΔsimA mutant, S. iniae WT 02161A strain (with a frameshift mutation truncating the simA ORF) was attenuated compared to strain K288 in the HSB IP challenge model (P<0.005) (Fig. 6A). In contrast, allelic replacement of the scpI gene encoding a C5a peptidase-like protein did not significantly reduce S. iniae virulence in the IP model (P = 0.31) (Fig. 6A) and was actually associated with an increase in the kinetics of killing compared to WT K288 in the IM challenge model (P<0.01) (Fig. 6B). A zebrafish IM challenge model has also been developed for analysis of virulence factors of streptococcal pathogens [40], including the observed attenuation of a GAS C5a peptidase (ScpA) mutant compared to its parent strain [41]. We found that the S. iniae ΔsimA mutant showed evidence of attenuation in this zebrafish model, producing no mortalities, though this trend did not achieve statistical significance due to low WT mortalities (P = 0.067). Challenge with the isogenic ΔscpI mutant generated no evidence of attenuation and a similar mortality curve to the WT K288 S. iniae parent strain in the zebrafish model (P = 0.985) (Fig. 6C). Based on the composite in vivo fish challenge experiments, we conclude S. iniae M-like protein SiMA plays a significant role in S. iniae invasive disease pathogenesis, while the C5a peptidase-like protein ScpI alone is not required for fish virulence upon systemic challenge by injection.


Figure 6. M-like protein contributes to S. iniae virulence in HSB and zebrafish infection models.

(A) Juvenile hybrid striped bass (HSB) (n = 10) were injected IP with 3×105 CFU of WT K288 S. iniae, the ΔsimA and ΔscpI isogenic mutants, or WT 02161A (possesses a natural frameshift mutation in simA). (B) Juvenile HSB (n = 10) were injected IM with 3×105 CFU of WT K288 S. iniae, or the ΔsimA and the ΔscpI mutants. (C) Adult zebrafish (n = 10) were injected IM with 4×105 CFU of WT K288 S. iniae or the ΔsimA and the ΔscpI mutants.


SiMA does not protect S. iniae against cationic AMPs

AMPs are an evolutionarily conserved innate defense mechanism [42], and likely play a role in fish resistance to bacterial infection [43]. The increased sensitivity of an S. iniae phosphoglucomutase mutant to cationic AMPs demonstrates the importance of S. iniae to protect against antimicrobial defenses [9]. To determine if enhanced AMP resistance represent a contribution of SiMA to S. iniae virulence, we tested the susceptibility of the ΔsimA mutant to three AMPs: Bacillus-derived polymyxin B, HSB derived-moronecidin, and murine-derived CRAMP. Both WT and ΔsimA mutant S. iniae strains were sensitive to all three AMPs and killed with similar efficiency: 99.10±0.03% WT vs. 99.38±0.03% ΔsimA killing by 60 µM polymyxin B in 120 min; 99.21±0.06% WT vs. 98.74±0.14% ΔsimA killing by 1.5 µM moronecidin in 15 min; 99.98±0.05% WT vs. 99.92±0.47% ΔsimA killing by 16 µM CRAMP in 30 min. We conclude that SiMA does not likely contribute to relative resistance of S. iniae to cationic AMPs.

SiMA contributes to S. iniae adherence to and invasion of fish epithelial cells

The ability to adhere to and invade epithelial layers is proposed to play a role in S. iniae virulence [44]. We used cultured monolayers of the white bass epithelial cell line WBE27 to assess the adherence and intracellular invasive properties of S. iniae strains in vitro [45]. Compared to the WT parent strain K288, the S. iniae ΔsimA mutant demonstrated significantly less adherence to (~40% reduction, P<0.005) and invasion (~20% reduction, P<0.02) of WBE27 cells (Fig. 7A, B). The levels of adherence and invasion associated with the S. iniae WT 02161A strain (harboring a frameshift/truncation mutation in the simA gene) had a similar trend (P = 0.0067, P<0.0001, respectively) to those of the S. iniae K288 ΔsimA mutant (Fig. 7A, B).


Figure 7. M-like protein contributes to S. iniae adherence to and invasion of cultured fish epithelial cells and resistance to killing by fish macrophages.

(A) Adherence and (B) invasion characteristics of WT K288, the isogenic ΔsimA allelic mutant, and the naturally M-deficient WT 02161A S. iniae strain for the fish epithelial cell line WBE27. (C) Survival of WT K288, WT 02161A, and the ΔsimA mutant upon co-incubation with CLC fish macrophage/monocytes for 2, 4, or 18 h. Significance indicated as: * P<0.05, ** P<0.005, *** P<0.0005. Data are presented as mean±SEM from two-tailed t-tests.


SiMA contributes to S. iniae macrophage resistance

Another described virulence property of S. iniae is its ability to resist phagocytosis and survive within fish leukocytes [46]. To determine if M-like protein SiMA promotes bacterial survival when exposed to phagocytic cells, a killing assay with the carp macrophage cell line CLC was performed. The survival of the ΔsimA mutant in the presence of macrophages was similar to that of the parent strain at early time points (2 h and 4 h), however by 18 h survival of the ΔsimA mutant was reduced over 2 logs compared to WT K288 (P<0.0001) (Fig. 7C). The WT 02161A strain possessing the frameshift/truncation mutation in the simA gene also showed significantly diminished survival compared to WT strain K288 by the 18 h time point (P<0.0001) (Fig. 7C).

The attenuated ΔsimA mutant confers adaptive immune protection against S. iniae infection

Previous work demonstrated the effectiveness of an attenuated S. iniae phosphoglucomutase mutant to protect HSB against subsequent challenge with WT S. iniae [9]. Because the ΔsimA mutant shows significant attenuation in our HSB infection challenges, we investigated its potential to serve as a live attenuated vaccine. IP vaccination of HSB with two different doses of the ΔsimA mutant (3×104 and 3×106 CFU) resulted in 8% mortality in each group. No mortality was observed in the PBS mock vaccination group. Following a holding period of 90 days (~1,400 degree days), both vaccinate groups were completely protected from a lethal dose (LD96, 5×105 CFU) of WT K288 S. iniae (Table 2), demonstrating the high protective capacity of this mutant as a live vaccine candidate.


Table 2. Immune protection conferred by the ΔsimA mutant in HSB.



To further understanding of S. iniae virulence, we used whole genome pyrosequencing to identify and characterize the S. iniae homologues of two well-established, Mga-regulated GAS virulence factors, M-like protein (simA) and C5a peptidase (scpI). We identified in S. iniae strain K288 a mga-like locus containing the M-like protein gene simA and a putative mga-like regulatory gene mgx, identical in arrangement to a locus recently described in S. iniae strain QMA0076 [29]. The GAS Mga locus contains several downstream virulence genes regulated by Mga, including genes encoding M-proteins and C5a peptidase. Though S. iniae does possess a putative tellurite resistance protein gene (telX) downstream of sim (which may potentially have a role in virulence) there are no typical GAS Mga locus-like candidate virulence genes in the Mgx locus aside from sim. Also of note is that unlike the GAS Mga locus (and Mga-like loci in GCS/GGS), mgx is transcribed divergently from M-protein homologue sim, similar to the chromosomal juxtaposition of the closely related S. uberis lactoferrin binding protein gene and its putative mga-like regulator [30]. Additionally, the C5a peptidase-like gene (scpI) is positioned distally on the chromosome from simA and mgx, a chromosomal arrangement more similar to that of GCS and GGS than GAS [36]. The presence of two adjacent Mga-like genes (one of which has been disrupted with mutations in some strains) is a unique property of S. iniae and may hold clues to the evolution of Mga-family genes in this species. Gene duplications in the Mga locus are thought to account for the diversity of GAS M family genes [47], though we have not found any reports of duplications in mga or mga-like genes. The functionality of mgx2 in strain 02161A, and whether the mutations leading to a disrupted simA gene and the creation of a second putative mgx gene represent an alternative virulence strategy in this strain, are interesting areas for investigation. Sequence upstream of simA with strong similarity to the Mga transcriptional regulatory binding domains of GAS M proteins suggests that Mgx regulation of simA expression is likely to occur in S. iniae. This hypothesis is strengthened by predicted structural analysis of Mgx that indicates helix-turn-helix domains [29], a feature present in DNA-binding Mga and Mga-like regulatory proteins [48].

C5a peptidase has highly specific endoproteolytic activity against the complement system polymorphonuclear leukocyte chemotaxin C5a [26], [27], thereby altering neutrophil trafficking to the site of infection [49], [50]. C5a peptidase also acts as an adhesin in GBS through binding to host fibronectin [51], [52] and in GAS through fibronectin independent binding [28]. Allelic replacement of the S. iniae scpI gene encoding a predicted C5a peptidase-like surface protein did not significantly attenuate virulence in our analyses using HSB and zebrafish infection models. While Scp inhibition of leukocyte chemotaxis is well documented in other streptococci [26], [27], inactivation of this gene does not always translate into a reduction in overall in vivo virulence [53][55]. Teleosts do possess a potent complement system [56], [57], a functional C5a homologue [58], [59], and a corresponding receptor [60], [61], so it is plausible that a fish pathogen would target components of this pathway. Additionally, S. iniae may possess other gene encoded determinants with functional redundancy to ScpI, masking virulence effects in our challenge systems. For example, in our genomic sequence analysis we also identified a putative C3 proteinase (data not shown) which may serve to inactivate the complement system upstream of C5a peptidase.

It appears that there is not a high degree of variation among SiM proteins. Sequencing a panel of 11 diverse S. iniae isolates generated only one significant sequence variation. We report an insertional frameshift mutation of the simA gene in S. iniae strain 02161A that splits the coding region into two smaller ORFs of unknown function, and note that this strain is attenuated in the HSB model. In GAS, frameshift mutations followed by compensatory mutations that bring the gene back into frame are proposed to play a role in antigenic variation of M proteins [62], a scenario that may play out over time in 02161A to generate a novel sim allele. The only other documented sim allele, simB, was found in strain QMA0141 as part of a similar comparative analysis of sim sequences [29]. These findings contrast the extreme variation in allele types for M-protein in GAS [63]. The functional implications of this conservation among sim alleles warrant further investigation. Additional sequencing efforts are needed to gauge the degree of S. iniae M-like protein sequence divergence and to determine if this surface protein may contribute as a serotyping determinate.

M family proteins have been shown to play a prominent role in colonization through adherence in multiple host pathogen systems [18], [19]. In GAS, adherence mediated by M family proteins is not universal to all cell types, but has been shown to be particularly important in binding to keratinocytes [64] and Hep-2 cells [65]. The ability to invade non-immune cell types has also been linked to the GAS M protein [66]. Consistent with these roles we observed a decrease in adherence and invasion of the white bass epithelial cell line by the S. iniae ΔsimA mutant.

A primary function function of M-like proteins involves resistance to phagocytic clearance mechanisms [67][69]. Through binding to serum proteins such as immunoglobulins, fibrinogen, and the complement regulator, factor H, M family proteins can effectively avoid phagocytosis through prevention of complement deposition. M proteins have also been shown to confer intracellular protection against phagocytic killing [21]. Similarly for SiMA, in the presence of fish macrophages, we observed over a 2 log-fold reduction in survival in the ΔsimA mutant compared to WT K288. Our findings confirm a role for SiM in evading phagocytosis, as suggested in studies linking SiM with fibrinogen binding [29].

Our live attenuated vaccine development approach contrasts typical M protein vaccine strategies which use the protein itself or fragments thereof as the immunogen. Such vaccination strategies for the GAS M protein have required multimeric vaccines to ensure protection against a panel of relevant serotypes [70], [71]. The generation of an autoimmune response through production of cross reactive antibodies [72], [73] against M proteins that demonstrate molecular mimicry of host tissues [74], [75] has also been a significant hurdle to GAS protein based vaccine development efforts. Whether either of these is issues is a concern in for SiM is unknown, but by deleting the M-like protein from S. iniae and relying on other key antigenic epitopes, both of these potential issues are circumvented in our live vaccine approach. Live attenuated vaccines also offer the advantage of prolonged, unaltered antigen presentation which can stimulate a more robust humoral and cell-mediated immune response, resulting in greater adaptive immune protection compared to inactivated bacterins or subunit vaccines in fish [76][78]. Successful demonstrations of live vaccines have been employed for a number of bacterial finfish pathogens [79][81] including S. iniae [9]. Though limited mortality was observed in our vaccinations with the ΔsimA mutant, further attenuation of this strain by targeted gene disruption of additional proven virulence determinants will likely be required to provide an optimal safety profile.

In sum, through sequence analysis of the S. iniae genome we have identified two putative homologues of classic surface-anchored streptococcal virulence determinants, M-like protein and C5a peptidase. Allelic replacement of these two genes and analyses using our models of bacterial pathogenesis revealed that M-like protein plays a significant role in S. iniae virulence whereas C5a peptidase-like protein does not. Future research will investigate the regulation of these genes and their specific protein-ligand interactions. The M-like protein mutant created in this research holds promise as live attenuated vaccine. Subsequent vaccination studies will test alternative delivery options and the long-term efficacy of the ΔsimA mutant as a live attenuated vaccine in aquaculture.

Materials and Methods

Bacteria strains, culture, transformation, and DNA techniques

The WT virulent S. iniae strain K288, isolated from the brain of a diseased HSB at the Kent SeaTech (KST) aquaculture facility in Mecca, CA [9], served as a background for generation of the ΔsimA and ΔscpI isogenic mutants. Additional S. iniae isolates used for comparative DNA sequence analysis are listed in Table 1. S. iniae was grown at 30°C (unless otherwise stated) in Todd-Hewitt broth (THB, Hardy Diagnostics) or on THB agar (THA). Enumeration of colony-forming units (CFU) was done through serial dilution of samples in PBS and plating on THA. β-hemolytic activity was assessed on sheep blood agar (SBA) plates (tryptic soy agar with 5% sheep red blood cells). For all assays, overnight cultures of S. iniae were diluted 1:10 in fresh THB and grown to mid-log phase (OD600 = 0.40). S. iniae strains were rendered electrocompetent for transformation through growth in THB media containing 0.6% glycine following procedures described for GBS [82]; transformants were propagated at 30°C in THB with 0.25 M sucrose. Antibiotic selection was achieved with chloramphenicol (Cm) at 2 µg/ml or erythromycin (Erm) at 5 µg/ml. Escherichia coli used in cloning were grown at 37°C (unless otherwise stated), shaking, under aerobic conditions in Luria-Bertani broth (LB, Hardy Diagnostics) or statically on agar (LA). When necessary, E. coli were grown in antibiotics: ampicillin (Amp) at 100 µg/ml, spectinomycin (Spec) at 100 µg/ml, Erm at 500 µg/ml, or Cm at 20 µg/ml. Mach 1 chemically-competent E. coli (Invitrogen) and electrocompetent MC1061 E. coli used in transformations were recovered through growth at 30°C in S.O.C. media (Invitrogen). A PureLink™ Quick Plasmid Miniprep Kit (Invitrogen) was used to isolate plasmids propagated in E. coli. S. iniae genomic DNA was isolated using a Colony Fast-Screen™ Kit (EPICENTRE Biotechnologies) or an UltraClean DNA Isolation Kit (MoBio).

Cell lines and culture conditions

The adherent CLC carp monocytic/macrophage cell line (European Collection of Cell Cultures no. 95070628) and the WBE27 white bass embryonic epithelial cell line (ATCC no. CRL-2773) [83] were grown at 28°C with 5% CO2. Cells were maintained in 125-ml tissue culture flasks in DMEM media (Gibco) containing 10% heat-inactivated fetal bovine serum (FBS, Gibco).

Allelic exchange mutagenesis

Allelic exchange mutagenesis of simA (Fig. 1A) and scpI (Fig. 1B) with a chloramphenicol resistance gene, cat, was carried out as previously described for S. iniae [7]. A list of primers used to generate and confirm the allelic replacement mutants is provided (Table 3). PCR was used to amplify ~1,000 bp of S. iniae chromosomal DNA fragments directly upstream and downstream of simA (primers 4+5, 6+7) and scpI (primers 10+11, 12+13), with primers adjacent to each gene constructed to possess 25 bp 5′-extensions corresponding to the 5′- and 3′- ends of the chloramphenicol acetyltransferase (cat) gene from pACYC [84], respectively. The upstream (Up) and downstream (Down) PCR products were then combined with a 660-bp amplicon of the complete cat gene (generated with primers 1+2) using fusion PCR (primers 4+7 for simA, 10+13 for scpI) [85]. The resultant PCR amplicon containing an in-frame substitution of simA and scpI with cat was subcloned into the Gateway entry vector pCR8/GW/TOPO (Invitrogen) and transformed into Mach 1 E. coli (Invitrogen). Plasmid DNA was extracted and a Gateway LR recombination reaction was performed to transfer the fusion PCR amplicon into the corresponding Gateway entry site of a temperature-sensitive knockout vector pKODestErm (a derivative of pHY304 [86] created for Gateway cloning), thereby generating the knockout plasmids pKOsimA and pKOscpI. The knockout constructs were introduced into WT K288 S. iniae by electroporation. Transformants were identified at 30°C by Erm selection then shifted to the nonpermissive temperature for plasmid replication (37°C). Differential antibiotic selection (CmR and ErmS) was used to identify candidate allelic exchange mutants. Targeted in-frame replacement of both genes was confirmed unambiguously by PCR reactions (primers 3+8 for simA, 9+14 for scpI) documenting the desired insertion of cat and absence of simA and scpI sequence in chromosomal DNA isolated from the final isogenic mutants, ΔsimA and ΔscpI.


Table 3. Primers used to generate and confirm ΔsimA and ΔscpI allelic mutants.


Identification of M-like protein and C5a peptidase homologues

Short contigs generated from pyrosequencing (454 Life Sciences) of the S. iniae K288 genome were assembled using the Phred/Phrap/Consed suite (​ml), resulting in 1865 contigs ranging in size from 51 bp to 22 kb. Without the need of further assembly, we used these contigs to build our S. iniae genome database that we used for BLAST searches. Using a local version of BLAST (version 2.2.14) [87], BLAST analysis of each contig against GAS M1 (GenBank Accession No. NC_002737) and M3 (GenBank Accession No. NC_004070) genomic sequences revealed the presence of putative M-like protein and C5a peptidase homologues. The contigs possessing hits for M-like protein and C5a peptidase genes were analyzed using Vector NTI software (Invitrogen) to assign open reading frames. Single-primer PCR [88] was used to sequence out from the contig ends in order to generate complete target gene sequences and provide at least 1,000 bp of flanking genomic sequence for use in allelic exchange mutagenesis. Finally, genomic regions containing simA and scpI were resequenced using standard BigDye sequencing techniques (Eton Bioscience Inc.) to confirm data generated in the initial sequencing efforts. Results from our K288 genomic analysis were compared with preliminary S. iniae (strain 9117) sequence data obtained from the BCM-HGSC website (

Public reporting of sequence data

Sequences for simA and surrounding chromosomal genes for S. iniae strains K288 and 02161A were deposited in the GenBank database under accession numbers EU693238 and EU714186, respectively. Sequences for scpI and flanking genes in strain K288 were deposited under the accession number EU693239.

Bioinformatic analyses

The amino acid sequences of all proteins were retrieved from the National Microbial Pathogen Data Resource (NMPDR) database ( by the use of the SEED similarity tool [89] and the NMPDR bidirectional best-hit engine [90]. For confirmation and completion of any missing sequences, the procedure was repeated by the use of BlastP and tBlastN algorithms [87] to search the non-redundant protein database (nr proteins) filtered to the genus Streptococcus. SignalP version 3.0 algorithm was used to screen the proteins sequences for Gram-positive leader peptides [91]. Several tools were used for motif finding, including InterPro [92], Pfam [93], in addition to FigFam [94] FASTA-formatted protein sequences were used as an input for the ClustalW software [95], [96] available as a part of the Biology Workbench Server, ( [97]. Phylogenetic distances of the alignment results were calculated by Phylip analysis [98], and phylogenetic trees were drawn by DrawGram [97].

Red blood cell hemolysis

Fresh, heparinized, whole HSB blood was diluted 1:1 with HBSS (no Ca2+ or Mg2+) and 8 ml added to the top of a layered Percoll (Sigma) gradient containing 8 ml of 1.06, 1.07, and 1.08 g/ml solutions. The tube was centrifuged at RT for 30 min at 350×g. Red blood cells were taken from the bottom of the 1.08 g/ml density layer, washed three times in 20 volumes of PBS, and resuspended as a 2% solution (v/v). In a 96-well round bottom plate, mid-log cultures of bacteria were aliquoted in quadruplicate in volumes of 100 µl. Each well then received 100 µl of the 2% fish blood solution. Background lysis was measured in wells containing only blood cells and THB. Complete lysis was measured by wells containing blood cells, sterile THB, and 2 µl of Triton X-100. Plates were incubated at 30°C for 2 h then at 4°C for 2 h. Following centrifugation at 1,500×g for 5 min, 100 µl from each well was added to a new flat-bottom 96-well plate and the optical density was read at 405 nm in a microplate reader (Molecular Devices).

Cell surface charge

In triplicate, overnight cultures of each S. iniae strain were diluted 1:10 and grown to mid-log phase. Five ml of each culture was washed once in PBS prior to resuspension in 400 µl of MOPS buffer (pH 7.0). Next, 100 µl of a 5 mg/ml solution of cytochrome c (Sigma) was added. The solution was mixed thoroughly and incubated at room temp for 15 min. The bacterial suspension was pelleted (16,000×g for 5 min) and 200 µl of the supernatant was added to new flat-bottom 96-well plate. Controls included MOPS alone and MOPS with the same proportionate amount of cytochrome c. The amount of unbound cytochrome c was determined by absorbance of the supernatant at 530 nm.

HSB virulence challenges

In vivo virulence attenuation of ΔsimA and ΔscpI mutants was assessed in juvenile (~15 g) HSB (Morone chrysops×Morone saxatilis) as previously described [7]. Groups of 10 fish per treatment group were injected intraperitoneally (IP) or intramuscularly (IM) in the dorsal muscle with 3×105 CFU suspended in 50 µl of PBS. Fish were maintained at 24°C in aerated, 113-l flow-through tanks and monitored one week for survival. All Fish challenges were carried out in an AAALAC-certified facility following IACUC-approved protocols.

Zebrafish virulence challenges

Adult zebrafish (Danio rerio, strain EKW) were challenged IM (n = 10 fish per treatment group) with 5×104 CFU of ΔsimA, ΔscpI, or WT K288 as previously described [40]. Mid-log phase bacteria were diluted in PBS and injected in 10-µl volumes using a 0.3 cc syringe with a 29-gauge needle. Fish were maintained at 28°C in recirculated, 10-l aquariums. Survival was monitored for one week post challenge.

Antimicrobial peptide (AMP) killing assays

AMPs moronecidin [43], polymyxin B (Sigma), and CRAMP [99] were diluted in distilled H2O to 15, 600, or 160 µM, respectively. In a 96 well round bottom plate 10 µl of each AMP solution was added to 90 µl of THB containing ~1×105 CFU bacteria taken from a mid-log phase culture. The plate was incubated at 30°C. At each time point a 25-µl aliquot was removed, serially diluted in THB, and plated on THA. Survival was calculated by dividing surviving CFU from each time point by the starting CFU for each strain.

Invasion and adherence assays

Invasion and adherence assays were performed in collagen-coated 96-well tissue culture plates (Nunc) using confluent monolayers of WBE27 white bass epithelial cells. Mid-log phase bacteria were centrifuged at 3,500×g for 5 min then washed once in PBS. Bacteria were then resuspended in DMEM containing 2% FBS and added to each well in 100 µl volumes to achieve a multiplicity of infection (MOI) of 5 (bacteria:cells). Following centrifugation at 350×g for 10 min, the plate was incubated for 60 min at 28°C with 5% CO2. The cells were then washed twice with DMEM containing 2% FBS and incubated in fresh DMEM with 30 µg/ml penicillin (Invitrogen) and 300 µg/ml of gentamicin (Invitrogen) for 60 min to kill extracellular bacteria. Cells were then washed twice with DMEM containing 2% FBS and lysed by trituration in 100 µl of 0.025% Triton X-100 (Sigma). Surviving intracellular bacteria were quantified by plating serial dilutions of lysed cell supernatant on THA. The 30 min adherence assays were carried out in a similar manner except that no antibiotics were used and wells were washed five times with DMEM containing 2% FBS to remove non-adherent bacteria prior to trituration and enumeration of CFU.

Macrophage survival assay

Monolayers of carp macrophages (CLC) were grown as described for the invasion and adherence assays. Bacteria were washed once in PBS then diluted in DMEM containing 2% FBS, added to the cells at an MOI of 0.05, and incubated at 28°C for 2, 4, or 18 h. Without washing, 25 µl of a 0.125% Triton X-100 solution was added to each well (0.025% final concentration). Cells were lysed and bacteria were plated as described above for invasion and adherence assays. Survival was calculated as a percentage of the input inoculum.

HSB vaccine trials

Live attenuated vaccine challenges of ΔsimA were carried out similar to the HSB virulence studies described above. Single groups of 25 HSB (~21 g) were fin clipped to indicate treatment group and injected IP with a 100 µl volume containing 3×104 or 3×106 CFU of the ΔsimA mutant or with PBS alone. Fish were held at 24°C for 2 weeks in 113-l aerated, flow-through tanks. Fish were cohabitated in a 1,071-l recirculating tank and held at 14-16°C for 1400 degree days (~90 days total). Fish were then sorted by treatment group into 113-l challenge tanks and acclimated to 24°C over a period of 2 days. Each group was then challenged with a 100-µl IP injection of 5×105 CFU of WT S. iniae. Survival was monitored for 2 weeks.

Statistical analyses

Data analyses were performed using the statistical tools included with GraphPad Prism 5 (GraphPad Software, Inc.). In vitro assay data were analyzed using unpaired two-tailed t-tests. Fish infection survival data were analyzed using a Logrank Test. P<0.05 was considered statistically significant. In vitro assays were repeated three times (with equivalent results), in quadruplicate, and data presented (mean±standard error of the mean, SEM) are from a single representative assay. In vivo fish challenges were repeated twice with equivalent results and data from a single experiment are shown.

Supporting Information

Figure S1.

Full length amino acid sequence alignment among SiMA and M family proteins with highest similarity. Strain abbreviations: SIn-S. iniae, SPy-S. pyogenes, SUb-S. uberis, SEq-S. equi, and SDy-S. dysgalactiae


(24.65 MB TIF)

Figure S2.

Amino acid alignment of ScpI with GAS and GBS C5a peptidases. ScpI shows high sequence similarity to the closest C5a peptidase homologues from GAS (ScpA, SPy Manfredo M5 strain) and GBS (ScpB, SAg A909 strain). ScpI possesses the conserved LPXTN Gram-positive surface anchor motif (dark line) as well as the Asp-His-Ser catalytic triad residues (asterisks), though proteolytic function of ScpI is unknown.


(13.22 MB TIF)


We thank Kent SeaTech Corporation for the use of their fish and challenge facilities. We thank Dr. John Hawke at Louisiana State University and Dr. Ricardo Russo at the University of Florida for supplying S. iniae strains. We also acknowledge: Dr. Lena Gerwick for providing use of zebrafish challenge facilities, Tristan Carland for assistance with the zebrafish challenges, Carlo Milani for help with the vaccine studies, Dr. Xavier Lauth for providing moronecidin and zebrafish, Dr. Bernard Beall for his M protein expertise, Dr. Rob Edwards for his assistance with processing the 454 sequence data, and Dr. Sarah Highlander for her assistance with the BCM-HGSC 9117 sequence data.

Author Contributions

Conceived and designed the experiments: JBL MRV VN JB. Performed the experiments: JBL MRV. Analyzed the data: JBL RKA VN JB. Contributed reagents/materials/analysis tools: RKA MRV JB. Wrote the paper: JBL RKA VN JB.


  1. 1. Shoemaker CA, Klesius PH, Evans JJ (2001) Prevalence of Streptococcus iniae in tilapia, hybrid striped bass, and channel catfish on commercial fish farms in the United States. Am J Vet Res 62: 174–177.
  2. 2. Pier GB, Madin SH (1976) Streptococcus iniae sp.nov., a beta-hemolytic streptococcus isolated from an Amazon freshwater dolphin, Inia geoffrensis. Intl J system Bacteriol 545–553.
  3. 3. Weinstein MR, Litt M, Kertesz DA, Wyper P, Rose D, et al. (1997) Invasive infections due to a fish pathogen, Streptococcus iniae. S. iniae Study Group. N Engl J Med 337: 589–594.
  4. 4. Agnew W, Barnes AC (2007) Streptococcus iniae: an aquatic pathogen of global veterinary significance and a challenging candidate for reliable vaccination. Vet Microbiol 122: 1–15.
  5. 5. Locke JB, Colvin KM, Datta AK, Patel SK, Naidu NN, et al. (2007) Streptococcus iniae capsule impairs phagocytic clearance and contributes to virulence in fish. J Bacteriol 189: 1279–1287.
  6. 6. Lowe BA, Miller JD, Neely MN (2007) Analysis of the polysaccharide capsule of the systemic pathogen Streptococcus iniae and its implications in virulence. Infect Immun 75: 1255–1264.
  7. 7. Locke JB, Colvin KM, Varki N, Vicknair MR, Nizet V, et al. (2007) Streptococcus iniae β-hemolysin streptolysin S is a virulence factor in fish infection. Dis Aquat Organ 76: 17–26.
  8. 8. Fuller JD, Camus AC, Duncan CL, Nizet V, Bast DJ, et al. (2002) Identification of a streptolysin S-associated gene cluster and its role in the pathogenesis of Streptococcus iniae disease. Infect Immun 70: 5730–5739.
  9. 9. Buchanan JT, Stannard JA, Lauth X, Ostland VE, Powell HC, et al. (2005) Streptococcus iniae phosphoglucomutase is a virulence factor and a target for vaccine development. Infect Immun 73: 6935–6944.
  10. 10. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, et al. (2005) Genome sequencing in microfabricated high-density picolitre reactors. Nature 437: 376–380.
  11. 11. Lau SK, Woo PC, Tse H, Leung KW, Wong SS, et al. (2003) Invasive Streptococcus iniae infections outside North America. J Clin Microbiol 41: 1004–1009.
  12. 12. Perez-Casal J, Caparon MG, Scott JR (1991) Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems. J Bacteriol 173: 2617–2624.
  13. 13. Simpson WJ, LaPenta D, Chen C, Cleary PP (1990) Coregulation of type 12 M protein and streptococcal C5a peptidase genes in group A streptococci: evidence for a virulence regulon controlled by the virR locus. J Bacteriol 172: 696–700.
  14. 14. McIver KS, Heath AS, Green BD, Scott JR (1995) Specific Binding of the Activator Mga to Promoter Sequences of the emm and scpA Genes in the Group A Streptococcus. J Bacteriol 177: 6619–6624.
  15. 15. Hondorp ER, McIver KS (2007) The Mga virulence regulon: infection where the grass is greener. Mol Microbiol 66: 1056–1065.
  16. 16. Phillips GN Jr, Flicker PF, Cohen C, Manjula BN, Fischetti VA (1981) Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci U S A 78: 4689–4693.
  17. 17. Fischetti VA (1989) Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 2: 285–314.
  18. 18. Ellen RP, Gibbons RJ (1972) M protein-associated adherence of Streptococcus pyogenes to epithelial surfaces: prerequisite for virulence. Infect Immun 5: 826–830.
  19. 19. Caparon MG, Stephens DS, Olsen A, Scott JR (1991) Role of M protein in adherence of group A streptococci. Infect Immun 59: 1811–1817.
  20. 20. Fischetti VA, Gotschlich EC, Siviglia G, Zabriskie JB (1977) Streptococcal M protein: an antiphagocytic molecule assembled on the cell wall. J Infect Dis 136 Suppl S222–233.
  21. 21. Staali L, Morgelin M, Bjorck L, Tapper H (2003) Streptococcus pyogenes expressing M and M-like surface proteins are phagocytosed but survive inside human neutrophils. Cell Microbiol 5: 253–265.
  22. 22. Pahlman LI, Morgelin M, Eckert J, Johansson L, Russell W, et al. (2006) Streptococcal M protein: a multipotent and powerful inducer of inflammation. J Immunol 177: 1221–1228.
  23. 23. Herwald H, Cramer H, Morgelin M, Russell W, Sollenberg U, et al. (2004) M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 116: 367–379.
  24. 24. Lancefield RC (1962) Current knowledge of type-specific M antigens of group A streptococci. J Immunol 89: 307–313.
  25. 25. Larsen SA, Moody MD, Facklam RR (1970) Antigenic variation in group A streptococci: types 11 and 9. Appl Microbiol 20: 40–45.
  26. 26. Hill HR, Bohnsack JF, Morris EZ, Augustine NH, Parker CJ, et al. (1988) Group B streptococci inhibit the chemotactic activity of the fifth component of complement. J Immunol 141: 3551–3556.
  27. 27. Cleary PP, Prahbu U, Dale JB, Wexler DE, Handley J (1992) Streptococcal C5a peptidase is a highly specific endopeptidase. Infect Immun 60: 5219–5223.
  28. 28. Purushothaman SS, Park HS, Cleary PP (2004) Promotion of fibronectin independent invasion by C5a peptidase into epithelial cells in group A Streptococcus. Indian J Med Res 119 Suppl 44–47.
  29. 29. Baiano JC, Tumbol RA, Umapathy A, Barnes AC (2008) Identification and molecular characterisation of a fibrinogen binding protein from Streptococcus iniae. BMC Microbiol 8: 67.
  30. 30. Moshynskyy I, Jiang M, Fontaine MC, Perez-Casal J, Babiuk LA, et al. (2003) Characterization of a bovine lactoferrin binding protein of Streptococcus uberis. Microb Pathog 35: 203–215.
  31. 31. Vasi J, Frykberg L, Carlsson LE, Lindberg M, Guss B (2000) M-like proteins of Streptococcus dysgalactiae. Infect Immun 68: 294–302.
  32. 32. Fischetti VA, Pancholi V, Schneewind O (1990) Conservation of a hexapeptide sequence in the anchor region of surface proteins from gram-positive cocci. Mol Microbiol 4: 1603–1605.
  33. 33. Holden MT, Scott A, Cherevach I, Chillingworth T, Churcher C, et al. (2007) Complete genome of acute rheumatic fever-associated serotype M5 Streptococcus pyogenes strain manfredo. J Bacteriol 189: 1473–1477.
  34. 34. Tettelin H, Masignani V, Cieslewicz MJ, Donati C, Medini D, et al. (2005) Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial “pan-genome”. Proc Natl Acad Sci U S A 102: 13950–13955.
  35. 35. Carter P, Wells JA (1988) Dissecting the catalytic triad of a serine protease. Nature 332: 564–568.
  36. 36. Geyer A, Schmidt KH (2000) Genetic organisation of the M protein region in human isolates of group C and G streptococci: two types of multigene regulator-like (mgrC) regions. Mol Gen Genet 262: 965–976.
  37. 37. Smoot JC, Barbian KD, Van Gompel JJ, Smoot LM, Chaussee MS, et al. (2002) Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci U S A 99: 4668–4673.
  38. 38. Franken C, Haase G, Brandt C, Weber-Heynemann J, Martin S, et al. (2001) Horizontal gene transfer and host specificity of beta-haemolytic streptococci: the role of a putative composite transposon containing scpB and lmb. Mol Microbiol 41: 925–935.
  39. 39. Ferretti JJ, McShan WM, Ajdic D, Savic DJ, Savic G, et al. (2001) Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci U S A 98: 4658–4663.
  40. 40. Neely MN, Pfeifer JD, Caparon M (2002) Streptococcus-zebrafish model of bacterial pathogenesis. Infect Immun 70: 3904–3914.
  41. 41. Phelps HA, Neely MN (2005) Evolution of the Zebrafish Model: From Development to Immunity and Infectious Disease. Zebrafish 2: 87–103.
  42. 42. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, et al. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414: 454–457.
  43. 43. Lauth X, Shike H, Burns JC, Westerman ME, Ostland VE, et al. (2002) Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass. J Biol Chem 277: 5030–5039.
  44. 44. Eyngor M, Chilmonczyk S, Zlotkin A, Manuali E, Lahav D, et al. (2007) Transcytosis of Streptococcus iniae through skin epithelial barriers: an in vitro study. FEMS Microbiol Lett 277: 238–248.
  45. 45. Buchanan JT, Colvin KM, Vicknair MR, Patel SK, Timmer AM, et al. (2008) Strain-Associated Virulence Factors of Streptococcus iniae in Hybrid Striped Bass. Veterinary Microbiology In Press, Accepted Manuscript.
  46. 46. Zlotkin A, Chilmonczyk S, Eyngor M, Hurvitz A, Ghittino C, et al. (2003) Trojan horse effect: phagocyte-mediated Streptococcus iniae infection of fish. Infect Immun 71: 2318–2325.
  47. 47. Heath DG, Cleary PP (1989) Fc-receptor and M-protein genes of group A streptococci are products of gene duplication. Proc Natl Acad Sci U S A 86: 4741–4745.
  48. 48. Vahling CM, McIver KS (2006) Domains required for transcriptional activation show conservation in the mga family of virulence gene regulators. J Bacteriol 188: 863–873.
  49. 49. Ji Y, McLandsborough L, Kondagunta A, Cleary PP (1996) C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun 64: 503–510.
  50. 50. Wexler DE, Chenoweth DE, Cleary PP (1985) Mechanism of action of the group A streptococcal C5a inactivator. Proc Natl Acad Sci U S A 82: 8144–8148.
  51. 51. Cheng Q, Stafslien D, Purushothaman SS, Cleary P (2002) The group B streptococcal C5a peptidase is both a specific protease and an invasin. Infect Immun 70: 2408–2413.
  52. 52. Beckmann C, Waggoner JD, Harris TO, Tamura GS, Rubens CE (2002) Identification of novel adhesins from Group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding. Infect Immun 70: 2869–2876.
  53. 53. Husmann LK, Yung DL, Hollingshead SK, Scott JR (1997) Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia. Infect Immun 65: 1422–1430.
  54. 54. Hidalgo-Grass C, Mishalian I, Dan-Goor M, Belotserkovsky I, Eran Y, et al. (2006) A streptococcal protease that degrades CXC chemokines and impairs bacterial clearance from infected tissues. Embo J 25: 4628–4637.
  55. 55. O'Connor SP, Cleary PP (1987) In vivo Streptococcus pyogenes C5a peptidase activity: analysis using transposon- and nitrosoguanidine-induced mutants. J Infect Dis 156: 495–504.
  56. 56. Boshra H, Li J, Sunyer JO (2006) Recent advances on the complement system of teleost fish. Fish Shellfish Immunol 20: 239–262.
  57. 57. Nonaka M, Smith SL (2000) Complement system of bony and cartilaginous fish. Fish Shellfish Immunol 10: 215–228.
  58. 58. Boshra H, Peters R, Li J, Sunyer JO (2004) Production of recombinant C5a from rainbow trout (Oncorhynchus mykiss): role in leucocyte chemotaxis and respiratory burst. Fish Shellfish Immunol 17: 293–303.
  59. 59. Nonaka M, Natsuume-Sakai S, Takahashi M (1981) The complement system in rainbow trout (Salmo gairdneri). II. Purification and characterization of the fifth component (C5). J Immunol 126: 1495–1498.
  60. 60. Holland MC, Lambris JD (2004) A functional C5a anaphylatoxin receptor in a teleost species. J Immunol 172: 349–355.
  61. 61. Boshra H, Li J, Peters R, Hansen J, Matlapudi A, et al. (2004) Cloning, expression, cellular distribution, and role in chemotaxis of a C5a receptor in rainbow trout: the first identification of a C5a receptor in a nonmammalian species. J Immunol 172: 4381–4390.
  62. 62. Relf WA, Martin DR, Sriprakash KS (1994) Antigenic diversity within a family of M proteins from group A streptococci: evidence for the role of frameshift and compensatory mutations. Gene 144: 25–30.
  63. 63. Facklam RF, Martin DR, Lovgren M, Johnson DR, Efstratiou A, et al. (2002) Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124. Clin Infect Dis 34: 28–38.
  64. 64. Okada N, Pentland AP, Falk P, Caparon MG (1994) M protein and protein F act as important determinants of cell-specific tropism of Streptococcus pyogenes in skin tissue. J Clin Invest 94: 965–977.
  65. 65. Courtney HS, von Hunolstein C, Dale JB, Bronze MS, Beachey EH, et al. (1992) Lipoteichoic acid and M protein: dual adhesins of group A streptococci. Microb Pathog 12: 199–208.
  66. 66. Jadoun J, Burstein E, Hanski E, Sela S (1997) Proteins M6 and F1 are required for efficient invasion of group A streptococci into cultured epithelial cells. Adv Exp Med Biol 418: 511–515.
  67. 67. Podbielski A, Schnitzler N, Beyhs P, Boyle MD (1996) M-related protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes. Mol Microbiol 19: 429–441.
  68. 68. Timoney JF, Artiushin SC, Boschwitz JS (1997) Comparison of the sequences and functions of Streptococcus equi M-like proteins SeM and SzPSe. Infect Immun 65: 3600–3605.
  69. 69. Whitnack E, Beachey EH (1985) Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein. J Exp Med 162: 1983–1997.
  70. 70. Hu MC, Walls MA, Stroop SD, Reddish MA, Beall B, et al. (2002) Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun 70: 2171–2177.
  71. 71. Dale JB (2008) Current status of group A streptococcal vaccine development. Adv Exp Med Biol 609: 53–63.
  72. 72. Stollerman GH (1991) Rheumatogenic streptococci and autoimmunity. Clin Immunol Immunopathol 61: 131–142.
  73. 73. Massell BF, Honikman LH, Amezcua J (1969) Rheumatic fever following streptococcal vaccination. Report of three cases. Jama 207: 1115–1119.
  74. 74. Dale JB, Beachey EH (1985) Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med 162: 583–591.
  75. 75. Zabriskie JB, Freimer EH (1966) An immunological relationship between the group. A Streptococcus and mammalian muscle. J Exp Med 124: 661–678.
  76. 76. Marsden MJ, Vaughan LM, Foster TJ, Secombes CJ (1996) A live (delta aroA) Aeromonas salmonicida vaccine for furunculosis preferentially stimulates T-cell responses relative to B-cell responses in rainbow trout (Oncorhynchus mykiss). Infect Immun 64: 3863–3869.
  77. 77. Marsden MJ, Vaughan LM, Fitzpatrick RM, Foster TJ, Secombes CJ (1998) Potency testing of a live, genetically attenuated vaccine for salmonids. Vaccine 16: 1087–1094.
  78. 78. Thornton JC, Garduno RA, Newman SG, Kay WW (1991) Surface-disorganized, attenuated mutants of Aeromonas salmonicida as furunculosis live vaccines. Microb Pathog 11: 85–99.
  79. 79. Salonius K, Siderakis C, MacKinnon AM, Griffiths SG (2005) Use of Arthrobacter davidanieli as a live vaccine against Renibacterium salmoninarum and Piscirickettsia salmonis in salmonids. Dev Biol (Basel) 121: 189–197.
  80. 80. Vivas J, Riano J, Carracedo B, Razquin BE, Lopez-Fierro P, et al. (2004) The auxotrophic aroA mutant of Aeromonas hydrophila as a live attenuated vaccine against A. salmonicida infections in rainbow trout (Oncorhynchus mykiss). Fish Shellfish Immunol 16: 193–206.
  81. 81. Lawrence ML, Cooper RK, Thune RL (1997) Attenuation, persistence, and vaccine potential of an Edwardsiella ictaluri purA mutant. Infect Immun 65: 4642–4651.
  82. 82. Framson PE, Nittayajarn A, Merry J, Youngman P, Rubens CE (1997) New Genetic Techniques for Group B Streptococci: High-Efficiency Transformation-Sensitive pWV01 Plasmids, and Mutagenesis with Tn917. Appl Environ Microbiol 63: 3539–3547.
  83. 83. Shimizu C, Shike H, Malicki DM, Breisch E, Westerman M, et al. (2003) Characterization of a white bass (Morone chrysops) embryonic cell line with epithelial features. In Vitro Cell Dev Biol Anim 39: 29–35.
  84. 84. Nakano Y, Yoshida Y, Yamashita Y, Koga T (1995) Construction of a series of pACYC-derived plasmid vectors. Gene 162: 157–158.
  85. 85. Wang HL, Postier BL, Burnap RL (2002) Optimization of fusion PCR for in vitro construction of gene knockout fragments. Biotechniques 33: 26, 28, 30 passim.
  86. 86. Chaffin DO, Beres SB, Yim HH, Rubens CE (2000) The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon. J Bacteriol 182: 4466–4477.
  87. 87. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389–3402.
  88. 88. Karlyshev AV, Pallen MJ, Wren BW (2000) Single-primer PCR procedure for rapid identification of transposon insertion sites. Biotechniques 28: 1078, 1080, 1082.
  89. 89. Overbeek R, Begley T, Butler RM, Choudhuri JV, Chuang HY, et al. (2005) The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res 33: 5691–5702.
  90. 90. McNeil LK, Reich C, Aziz RK, Bartels D, Cohoon M, et al. (2007) The National Microbial Pathogen Database Resource (NMPDR): a genomics platform based on subsystem annotation. Nucleic Acids Res 35: D347–353.
  91. 91. Bendtsen JD, Nielsen H, von Heijne G, Brunak S (2004) Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340: 783–795.
  92. 92. Apweiler R, Attwood TK, Bairoch A, Bateman A, Birney E, et al. (2001) The InterPro database, an integrated documentation resource for protein families, domains and functional sites. Nucleic Acids Res 29: 37–40.
  93. 93. Finn RD, Tate J, Mistry J, Coggill PC, Sammut SJ, et al. (2008) The Pfam protein families database. Nucleic Acids Res 36: D281–288.
  94. 94. Aziz RK, Bartels D, Best AA, Dejongh M, Disz T, et al. (2008) The RAST Server: Rapid Annotations using Subsystems Technology. BMC Genomics 9: 75.
  95. 95. Higgins DG, Thompson JD, Gibson TJ (1996) Using CLUSTAL for multiple sequence alignments. Methods Enzymol 266: 383–402.
  96. 96. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673–4680.
  97. 97. Subramaniam S (1998) The Biology Workbench–a seamless database and analysis environment for the biologist. Proteins 32: 1–2.
  98. 98. Felsenstein J (1997) An alternating least squares approach to inferring phylogenies from pairwise distances. Syst Biol 46: 101–111.
  99. 99. Gallo RL, Kim KJ, Bernfield M, Kozak CA, Zanetti M, et al. (1997) Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem 272: 13088–13093.
  100. 100. Fuller JD, Bast DJ, Nizet V, Low DE, de Azavedo JC (2001) Streptococcus iniae virulence is associated with a distinct genetic profile. Infect Immun 69: 1994–2000.
  101. 101. Russo R, Mitchell H, Yanong RPE (2006) Characterization of Streptococcus iniae isolated from ornamental cyprinid fishes and development of challenge models. Aquaculture 256: 105.